Imexpharm Corporation announced earnings results for the full year of fiscal 2015. For the year, the company announced total revenue of VND 983.1 million and profit before tax of VND 131.7 million. Profit after tax was VND 92,654,232,705.

The company provided earnings guidance for the full year of fiscal 2016. For the year, the company expects total revenue to be VND 1,100 million and profit before tax to be VND 140 million.